|
Volumn 7, Issue 8, 1997, Pages 1031-1032
|
Benzothiadiazine dioxide acyclonucleosides as lead compounds for the development of new agents against human cytomegalovirus and varicella-zoster virus infections
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACICLOVIR;
ACYCLIC NUCLEOSIDE;
ANTIVIRUS AGENT;
BENZOTHIADIAZINE DERIVATIVE;
GANCICLOVIR;
ANTIVIRAL ACTIVITY;
ARTICLE;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
HUMAN CYTOMEGALOVIRUS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS 2;
IN VITRO STUDY;
VARICELLA ZOSTER VIRUS;
HUMAN HERPESVIRUS 3;
HUMAN HERPESVIRUS 5;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS 2;
|
EID: 0030934348
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0960-894X(97)00149-2 Document Type: Article |
Times cited : (15)
|
References (10)
|